Anatomy of a Successful Study Transition:
If I Knew Then What I Know Now
About this webinar
Although often not a component of the initial study plan, a contingency plan can be needed if a study is transitioned because of acquisition at the sponsor level, performance/capability issues or study re-design. When addressing this type of transition or “rescue” scenario, it is important to recognize the unique challenges that a study team will face. Because study conduct is already underway, the focus shifts beyond initial study implementation to the entire study process, requiring meticulous planning for simultaneous transition of administration, logistics and technology, as well as project and data management. Effective, efficient transition of study conduct requires consideration of not only the sponsor, CRO and associated service providers but also particularly the study sites, to avoid losing or potentially to regain or energize participating sites.
Who should attend
- Clinical Supply
- RTSM
- Interactive Response Technology
- Clinical Trial
- Clinical Operations
- Clinical Outsourcing
- Clinical Technology
- Data Management
- Regulatory
- Site Management
- Clinical Monitoring
- CMO, CSO, CIO
- TA Head
- Medical Monitors
- Clinical Scientists
- Imaging or Biomarkers Scientists
- Heads of: R&D, Clinical Research, Clinical Development, Clinical Operations
- Study/Project Manager
- Protocol Manager
- Study Startup
What you will learn
- Key considerations and learned lessons when transitioning mid-study
- Resource requirements for rapid deployment
- The effect of study stage on patient safety and regulatory considerations
Featured Speakers
Kevin Bishop
Kevin Bishop is a recognized clinical research senior executive with more than 30 years of operational and business leadership experience, the last 20 years of which have been in the high-growth eClinical technology space. In his current role, Bishop is responsible for driving the growth strategy for the Randomization & Trial Supply Management (RTSM) business, encompassing Bioclinica’s innovative IRT platform, clinical supply forecasting, optimization and planning services, as well as further developing Bioclinica’s unique project delivery methodology. Bishop has a Bachelor’s degree in Physiology and Pharmacology from the University of Southampton (UK).
Partner for this event
Bioclinica
Bioclinica is a global life-science provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new, life-improving therapies more efficiently and safely. The company’s offerings include medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments and budget forecasting; pharmacovigilance, and trial management.
Related webinars
More from Bioclinica.
Combining Adaptive Interactive Response Technology and Supply Chain Production with Management
Compensating for Limited Spatial Resolution of Positron Emission Tomography
Sources of Variability in Inflammatory Bowel Disease Endoscopic Video Interpretation
Enabling Decentralized Clinical Trials with Seamless, Remote Integration of Devices and eClinical Systems
Osteoarthritis Trials: The Role of Imaging for Subject Selection
MRI in Crohn’s Disease: Site Set-up and MREn Scoring Systems
Blood Pressure Monitoring in Clinical Trials: A Sponsor and Site Perspective
Getting Investigational Drugs to Patients in Decentralized Clinical Trials: Solutions and Key IRT Considerations
Gain the Benefits of eSource Without the Hassle of a Complex Integration
Designing a Successful Imaging-Based Pediatrics Clinical Trial
SharePoint-Enabled CTMS & eTMF for a Single Source of the Truth for Document, Content & Study Management
Quality Of Care In IBD: What Is It? How Can We Improve It?